Necrolytic migratory erythema following prolonged continuous subcutaneous dasiglucagon administration: a rare dermatologic adverse event

Clinical management of congenital hyperinsulinism (CHI) remains a significant challenge due to its complex pathophysiology and the limitations of available therapies. Dasiglucagon, a synthetic glucagon analog, represents a novel approach to managing CHI, particularly in patients where conventional t...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Lucas Weschle, Jenny Potratz, Frank Rutsch, Alexander Humberg, Sandra Oesingmann, Andreas Pascher, Alexander S Busch, Katja Masjosthusmann
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Bioscientifica 2025-04-01
Serie:	Endocrinology, Diabetes & Metabolism Case Reports
Soggetti:	necrolytic migratory erythema dasiglucagon congenital hyperinsulinism neonatal hypoglycemia
Accesso online:	https://edm.bioscientifica.com/view/journals/edm/2025/2/EDM-25-0006.xml
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!